1. Home
  2. HBNC vs SDGR Comparison

HBNC vs SDGR Comparison

Compare HBNC & SDGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Horizon Bancorp Inc.

HBNC

Horizon Bancorp Inc.

HOLD

Current Price

$18.28

Market Cap

883.5M

Sector

Finance

ML Signal

HOLD

Logo Schrodinger Inc.

SDGR

Schrodinger Inc.

HOLD

Current Price

$12.37

Market Cap

925.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HBNC
SDGR
Founded
1873
1990
Country
United States
United States
Employees
N/A
850
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
883.5M
925.8M
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
HBNC
SDGR
Price
$18.28
$12.37
Analyst Decision
Buy
Buy
Analyst Count
4
9
Target Price
$21.00
$21.00
AVG Volume (30 Days)
263.8K
1.4M
Earning Date
04-22-2026
05-05-2026
Dividend Yield
3.57%
N/A
EPS Growth
N/A
45.14
EPS
N/A
N/A
Revenue
N/A
$255,869,000.00
Revenue This Year
N/A
$0.76
Revenue Next Year
$5.52
$4.60
P/E Ratio
N/A
N/A
Revenue Growth
N/A
23.29
52 Week Low
$14.38
$10.95
52 Week High
$19.07
$27.63

Technical Indicators

Market Signals
Indicator
HBNC
SDGR
Relative Strength Index (RSI) 63.45 54.08
Support Level $15.69 $11.08
Resistance Level $18.72 $13.33
Average True Range (ATR) 0.49 0.71
MACD 0.03 0.04
Stochastic Oscillator 82.85 54.59

Price Performance

Historical Comparison
HBNC
SDGR

About HBNC Horizon Bancorp Inc.

Horizon Bancorp (IN) is a United States-based holding company providing banking services. It is engaged in providing commercial and retail banking services, corporate and individual trust and agency services, and other services incident to banking. The company also provides commercial loans, real estate loans, mortgage warehouse loans, consumer loans, and other credit facilities. The company has one principal business segment, commercial banking.

About SDGR Schrodinger Inc.

Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.

Share on Social Networks: